NCT07517250Recruiting
A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease Patients
Non-interventional Study on the Use of ILARIS® (Canakinumab) Among Familial Mediterranean Fever and Still's Disease Patients Across Europe and Israel
Source: ClinicalTrials.gov · Last updated 9 Jun 2026
Brief summary (registry, in English)
This study aims to assess and characterize the treatment patterns, and long-term clinical outcomes and demographic characteristics of patients diagnosed with Familial Mediterranean fever (FMF) and Still's disease (including systemic juvenile idiopathic arthritis \[SJIA\] and adult-onset Still's disease \[AOSD\]) that received canakinumab for at least 6 months.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 160 (estimated)
- First submitted
- 1 Apr 2026
- Start date
- 15 Mar 2026
- Primary completion date
- 3 Dec 2026
- Lead sponsor
- Novartis Pharmaceuticals
- Diseases
- Rheumatoid arthritis
- NCT number
- NCT07517250
What you commit to
- Study type: Observational
- Planned participants: 160
- From 15 Mar 2026 to the primary completion date, 3 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Patients Aged \<2 Years (24 Months) at Index Date.
Who the study is looking for
- Pediatric or adult patients who were prescribed canakinumab before October 2021 and received canakinumab for at least 6 months for the treatment of FMF or Still's disease (including SJIA or AOSD).
- Have data on clinical characteristics and treatments available for at least 3 years following the initiation of canakinumab treatment.
Age in the registry: 1 year to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Novartis Coordinator of this site? Confirm its status | Basel | Switzerland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.